LUYE PHARMA GROUP LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.960 HKD | +0.34% |
|
0.00% | -20.64% |
| 08-30 | Citi Upgrades Luye Pharma to Buy From Sell; Price Target is HK$4 | MT |
| 08-28 | Luye Pharma Group Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Bearish |
| Resistance | 3.060 | 3.060 | 3.170 |
| Spread/Res. | -3.27% | -3.27% | -6.62% |
| Spread/Supp. | +1.72% | +13.85% | +18.40% |
| Support | 2.910 | 2.600 | 2.500 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- 2186 Stock
- Charts Luye Pharma Group Ltd.
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition